0001362118-21-000003.txt : 20210422 0001362118-21-000003.hdr.sgml : 20210422 20210422180245 ACCESSION NUMBER: 0001362118-21-000003 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210418 FILED AS OF DATE: 20210422 DATE AS OF CHANGE: 20210422 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Strawn John R Jr CENTRAL INDEX KEY: 0001721394 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39785 FILM NUMBER: 21845979 MAIL ADDRESS: STREET 1: C/O IMMUDYNE, INC. STREET 2: 1460 BROADWAY CITY: NEW YORK STATE: NY ZIP: 10036 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LifeMD, Inc. CENTRAL INDEX KEY: 0000948320 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] IRS NUMBER: 760238453 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 800 THIRD AVENUE, SUITE 2800 CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: (866) 351-5907 MAIL ADDRESS: STREET 1: 800 THIRD AVENUE, SUITE 2800 CITY: NEW YORK STATE: NY ZIP: 10022 FORMER COMPANY: FORMER CONFORMED NAME: CONVERSION LABS, INC. DATE OF NAME CHANGE: 20180622 FORMER COMPANY: FORMER CONFORMED NAME: Immudyne, Inc. DATE OF NAME CHANGE: 20120514 FORMER COMPANY: FORMER CONFORMED NAME: IMMUDYNE INC DATE OF NAME CHANGE: 19950720 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2021-04-18 0 0000948320 LifeMD, Inc. LFMD 0001721394 Strawn John R Jr C/O LIFEMD, INC. 800 THIRD AVE, STE 2800 NEW YORK NY 10022 1 0 0 0 Common Stock, par value $0.01 2021-04-18 4 M 0 200000 1 A 203467 D Common Stock, par value $0.01 2021-04-18 4 F 0 20060 9.97 D 183407 D Common Stock, par value $0.01 2021-04-18 4 M 0 100000 2 A 283407 D Common Stock, par value $0.01 2021-04-18 4 F 0 20060 9.97 D 263347 D Common Stock, par value $0.01 60000 I Strawn Pickens LLP Option 1 2021-04-18 4 M 0 200000 0 D 2011-04-20 2021-04-20 Common Stock, par value $0.01 200000 0 D Option 2 2021-04-18 4 M 0 100000 0 D 2011-04-20 2021-04-20 Common Stock, par value $0.01 100000 0 D The Amount of Securities Beneficially Owned reflects a correction of an additional 467 shares from previous Form 3/A filing of the reporting person. Reflects 20,060 shares withheld by issuer to fund the cashless exercise of 200,000 options pursuant to the Reporting Person's Stock Option Agreement. Reflects 20,060 shares withheld by issuer to fund the cashless exercise of 100,000 options pursuant to the Reporting Person's Stock Option Agreement. Mr. Strawn has shared voting and dispositive power and as partner of Strawn Pickens LLP he shares a pecuniary interest. The shares were subject to a 1-for-5 reverse stock split in October, 2020. The original grant of 1,000,000 common stock options was subject to a 1-for-5 reverse stock split in October, 2020. The exercise reported herein is the shares remaining after the split. The original grant of 500,000 common stock options was subject to a 1-for-5 reverse stock split in October, 2020. The exercise reported herein is the shares remaining after the split. /s/ John R. Strawn, Jr. 2021-04-22